Newswise LOS ANGELES (April 4, 2017) - Two prominent Cedars-Sinai investigators one leading the development of biological treatments for heart disease, the other spearheading the design and analysis of clinical trials for cancer research were inducted April 3 into the Johns Hopkins University Society of Scholars.
Eduardo Marbn, MD, PhD, director of the Cedars-Sinai Heart Institute, and Steven Piantadosi, MD, PhD, director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, are among a select group of medical researchers to receive the honor.
Created in 1967, the society the first of its kind in the U.S. inducts former Johns Hopkins postdoctoral fellows, postdoctoral students and faculty members who have gained marked distinction in their respective fields. Members of the society include several Nobel laureates and Lasker Award winners.
Marbn and Piantadosi both led distinguished careers at Johns Hopkins University School of Medicine before joining the Cedars-Sinai faculty a decade ago. Shlomo Melmed, Cedars-Sinai executive vice president of Academic Affairs and dean of the medical faculty, said the honor was well-deserved.
Dr. Marbn has earned this prestigious honor for developing investigational stem cell and gene therapies for heart disease patients. His pioneering work has raised the hope that several irreversible conditions, such as heart failure, may actually be reversible, at least in part, Melmed said. Melmed added: Dr. Piantadosi has rightly been recognized with this high honor because of his incisive leadership in developing statistical design and analysis models of complex human investigations. His scholarly contributions have enriched discovery in multiple disease areas.
Before joining Cedars-Sinai, Marbn completed his medical residency and a fellowship in cardiology at Johns Hopkins, located in Baltimore. He then joined the Johns Hopkins faculty and eventually served as chief of Cardiology there.
He moved to Cedars-Sinai in 2007. Two years later, a team led by Marbn completed the worlds first cardiac stem cell infusion. Results from that clinical trial, published in The Lancet in 2012, showed the therapy resulted in a medical first: a stem cell infusion regenerated healthy heart muscle in a heart damaged by a heart attack.
Since then, Marbns research has led to several other clinical trials testing cardiosphere-derived stem cells (CDCs), targeting various types of heart disease, Duchenne muscular dystrophy and pulmonary arterial hypertension. Marbn also is pioneering a gene therapy project to create biological pacemakers as alternatives to electronic devices. Marbn served 10 years as editor-in-chief of Circulation Research and has been awarded numerous honors, including the Basic Research Prize of the American Heart Association.
Support for Marbns laboratory is provided by the National Institutes of Health, the California Institute for Regenerative Medicine and the U.S. Department of Defense. The stem cells used in his research are manufactured by Capricor Inc. (NASDAQ: CAPR) as their product CAP-1002 and have been used in numerous human clinical trials.
The process to grow cardiac-derived stem cells was developed by Marbn when he was on the faculty of Johns Hopkins and further developed at Cedars-Sinai. Capricor has licensed the process from Johns Hopkins and from Cedars-Sinai for clinical and commercial development. Capricor has licensed additional intellectual property from Cedars-Sinai and the University of Rome. Cedars-Sinai and Marbn have financial interests in Capricor.
Piantadosi is one of the worlds leading experts in the design and analysis of clinical trials for cancer research. Prior to assuming the directorship of the cancer institute, Piantadosi was a professor of Oncology at Johns Hopkins University School of Medicine and director of Biostatistics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He earned his medical degree from the University of North Carolina and doctorate in biomathematics from the University of Alabama at Birmingham. He was a senior staff fellow at the National Cancer Institute.
Piantadosi has advised dozens of academic programs and collaborations nationally regarding clinical trial design and conduct, and has served on external advisory boards for the National Institutes of Health and other prominent cancer programs and centers. He also has served on numerous Food and Drug Administration panels that decided approvals of new drugs, and on a Cancer Moonshot working group on clinical trials.
The investigator is the author of more than 260 peer-reviewed scientific articles, and has published extensively on research results, clinical applications and trial methodology. He also authored Clinical Trials: A Methodologic Perspective, which is widely considered a classic textbook for clinical trials. His collaborations expand to disciplines outside cancer, including lung disease and degenerative neurological disease. He has taught clinical trials extensively in the classroom and national workshop venues for young investigators.
Piantadosi, a member of the National Academies of Sciences, Engineering and Medicine health policy forum, currently leads Cedars-Sinais programs in cancer research, treatment and education, enhances academic activities related to cancer and brings together physicians and researchers for innovative collaborations.
Outside of the medical center, Piantadosi hand crafts violins, a skill he honed over several summers at the Violin Craftsmanship Institute at the University of New Hampshire, where he was instructed by the renowned German violin maker Karl Roy. The Public Library of Science recently published Piantadosis paper, Three-Dimensional Mathematical Modeling of Violin Plate Surfaces: An Approach Based on an Ensemble of Contour Lines.
# # #
Read more:
Pioneering Investigators in Experimental Heart Stem Cell and ... - Newswise (press release)
- Woman Who Conceived Twins in Rape Rejects Abortion, Shares How Her 21-Year-Old Twins Saved Her Life - The Epoch Times - October 13th, 2022
- Kid Captain Eli Belser takes the field with Hawkeyes, celebrating two years cancer free - UI The Daily Iowan - September 8th, 2022
- How space technology like the James Webb telescope is improving healthcare on Earth - The National - July 27th, 2022
- How COVID-19, Long COVID, and COVID Vaccines Differ Between Males and Females - CreakyJoints - July 27th, 2022
- Researchers find fabrication of artificial heart for transplant - ThePrint - July 19th, 2022
- Paolo Macchiarini - Wikipedia - July 3rd, 2022
- President Freeman Hrabowski prepares for retirement after turning UMBC into the top producer of Black M.D., Ph.D. graduates - Afro American - July 3rd, 2022
- Women find community in STEM fields at UA - The University of Alabama Crimson White - April 19th, 2022
- Poker Run event planned to benefit twins with rare syndrome - The Andalusia Star-News - Andalusia Star-News - April 6th, 2022
- Dr Borehams Crucible: Mesoblast within months of 3 major trial results, key regulatory decision - Stockhead - July 6th, 2020
- Alabama Stem Cells | Stem Cell TV - September 12th, 2019
- Only Cosmetic Stem Cell Therapy in Alabama - msbmd.com - April 20th, 2019
- Stem Cell Therapy in Houston, TX | National Stem Cell Centers - March 23rd, 2019
- Central Alabama Pain Management Center Established 1993 - March 6th, 2019
- Stem Cell Mobile Alabama 36607 - January 4th, 2019
- Stem Cell Birmingham Alabama 35282 - August 30th, 2018
- USA College of Medicine - University of South Alabama ... - July 24th, 2018
- Researchers find new glioblastoma inhibitor - Patient Daily - August 24th, 2017
- A Chip That Reprograms Cells Helps Healing, At Least In Mice - Alabama Public Radio - August 12th, 2017
- 'Happiness' Explores The Complex Push And Pull Of Human Relationships - Alabama Public Radio - August 12th, 2017
- Hampton Creek to enter clean meat market in 2018: 'We are building a multi-species, multi-product platform' - FoodNavigator-USA.com - June 30th, 2017
- Brain Tumors: Still Devastating, but Treatment Has Come a Long Way - Newswise (press release) - June 20th, 2017
- Walk for "terrible, awful" disease - Timmins Press - June 18th, 2017
- Rare disease hits 2 of family's 4 children - The Ledger - June 18th, 2017
- Hill-Rom Holdings, Inc. (HRC) Reaches $76.89 52-Week High, Biotime (NYSEMKT:BTX) Shorts Increased By 4.64% - UtahHerald.com - June 13th, 2017
- STEM College Students Who Learn by Example May Lack Key Attribute - GoodCall News (blog) - June 13th, 2017
- Wolf Evolution and Settled Science - PLoS Blogs (blog) - June 8th, 2017
- 3D-Printed Patch Mends Hearts - Photonics.com - June 6th, 2017
- When states have strong guns laws, they also have fewer fatal police shootings - Los Angeles Times - May 19th, 2017
- Top graduating senior in 'crazy race to the finish line' | Berkeley News - UC Berkeley - May 9th, 2017
- 3D-printed patch could lead to new treatments for patients after a heart attack - Biotechin.Asia - May 5th, 2017
- Meet Curry Cates: 2017 Big Man on Campus - The Auburn Plainsman - April 28th, 2017
- Andrews Institute Looks Ahead - Inweekly - April 27th, 2017
- UMN research team fixes broken hearts with 3D-printed tissue patch - Minnesota Daily - April 27th, 2017
- Bengals set to hold onto McCarron for at least 1 more year | Sports ... - Newsexaminer - April 27th, 2017
- Andrews Institute Celebrates Ten Years, Looks to Next Ten - WUWF - April 25th, 2017
- Scientists want to help you recover heart attack with a 3d printed patch - Industry Leaders Magazine - April 25th, 2017
- Bengals set to hold onto McCarron for at least 1 more year - WTOP - April 25th, 2017
- Mending broken hearts - The Sydney Morning Herald - April 22nd, 2017
- 3D-printed Patch Can Help Mend a 'Broken' Heart | Technology ... - Technology Networks - April 22nd, 2017
- UAB performs Alabama's first transplant where cadaver liver is 'kept ... - Medical Xpress - April 22nd, 2017
- Heart-healing patch has got the beat - New Atlas - April 20th, 2017
- 3D-printed Patch Can Help Mend a 'Broken' Heart - Technology Networks - April 19th, 2017
- 3D-Printed Patch Can Help Mend a 'Broken' Heart | Lab Manager - Lab Manager | News (press release) (blog) - April 18th, 2017
- 3D-printed patch can help mend a broken heart - UMN News - April 14th, 2017
- Bart Starr returns to Tijuana for stem cells - USA Today - April 10th, 2017
- The mystique of the invisible: Understanding mental illness - Glens Falls Post-Star - March 27th, 2017
- The Equities Research Analysts' Updated EPS Estimates for March, 20th (AIMT, AMID, AUPH, AVD, BDREF, BPTH ... - Petro Global News 24 - March 23rd, 2017
- Hettinger, ND gets state-of-art new clinic and vets - AG Week - March 21st, 2017
- Harvard Scientists Call For Better Rules To Guide Research On 'Embryoids' - Alabama Public Radio - March 21st, 2017
- State-of-art new clinic - and vets - The Dickinson Press - March 19th, 2017
- 3 Women Blinded By Unproven Stem Cell Treatments - Alabama Public Radio - March 16th, 2017
- Hot Biotech Stocks Recap: Nektar Therapeutics (NASDAQ:NKTR), Biostage, Inc. (NASDAQ:BSTG) - The Voice Registrar - March 7th, 2017
- Trump's coal council to drill down on advanced technology - Washington Examiner - March 6th, 2017
- Embryo Experiments Reveal Earliest Human Development, But Stir Ethical Debate - Alabama Public Radio - March 3rd, 2017
- Houston Solar Car featured in IMAX film, Smithsonian - Northeast Mississippi Daily Journal - February 24th, 2017
- News Scan for Feb 20, 2017 - CIDRAP - February 21st, 2017
- On Second Attempt, SpaceX Launches Rocket At NASA's Historic Pad - Alabama Public Radio - February 20th, 2017
- A Liftoff Deferred: SpaceX Mission From NASA's Historic Launch Pad Delayed - Alabama Public Radio - February 19th, 2017
- ECO VIEWS: Advertising is not just for humans - Tuscaloosa News - February 13th, 2017
- ECOViEWS: Advertising is not just for humans - Aiken Standard - February 11th, 2017
- Unsung: Jewel Plummer Cobb - Undark Magazine - February 8th, 2017
- Bart Starr prepares to watch Super Bowl from home as health keeps improving - USA TODAY - February 7th, 2017
- Romero '87 Sees ACLU Donations Soar, Munson *79 to Lead RIT, and More - Princeton Alumni Weekly - February 7th, 2017
- Meet the Team - The University of Alabama at Birmingham - January 26th, 2017
- Tallasee Dog Undergoes Stem Cell Procedure - Alabama News - December 30th, 2016
- Dermal fibroblast - Wikipedia - November 27th, 2016
- Stem Cell Hair Growth Huntsville | Steve Latham Hair ... - September 12th, 2016
- Adult Stem Cell Success - Children of God for Life - April 18th, 2015
- Can cancer vaccines prolong survival? - April 7th, 2015
- Human embryonic stem cells clinical trials - Wikipedia ... - February 19th, 2015
- Christian singer Carman shares testimony of cancer victory - February 2nd, 2015
- Urban Dictionary: stem cell - January 21st, 2015
- Huntsville blood bank to preserve umbilical cord tissues - November 25th, 2014
- CGS : 60 Minutes Exposes Stem Cell Scams Again - November 22nd, 2014
- What Are Stem Cells? (with pictures) - wiseGEEK - November 16th, 2014
- alabama StemCells Therapy StemCells Therapy - October 24th, 2014
- Life Issues Institute - Successes of Adult Stem Cell ... - October 16th, 2014
- A heartbeat away? Hybrid 'patch' could replace transplants - October 1st, 2014
- Huntsville AL Resources - Stem Cells: Get Facts on Uses ... - September 29th, 2014